Nature's nanomachines harnessed to make drugs

Nov 07, 2006

Many bacteria produce toxins that can threaten human health, however new research into how bacteria secrete these substances is giving clues as to how scientists could harness these processes to produce biopharmaceuticals. Researchers at the John Innes Centre (JIC) in Norwich have used state-of-the-art technology to study a nanomachine in soil bacteria called the Tat system, which the bacteria use to secrete a range of proteins that help them digest food and compete with other microorganisms in the soil.

The scientists' latest work, published today in the respected journal PNAS, identifies which proteins are exported via the Tat system, revealing that this system is used by more proteins than previously thought.

The biotechnology industry already uses bacteria to make proteins to use in products such as biological washing powder or pharmaceuticals, but some are difficult to produce using current methods. By harnessing the Tat system, the scientists hope that it will be easier to make these proteins for biotechnological and biomedical purposes.

The Tat nanomachine selects which proteins to secrete by recognising a short signal sequence attached to the end of the protein, explains Professor Tracy Palmer who has an MRC Fellowship with the University of East Anglia, " Our collaborators at the University of Pennsylvania have developed a computer program to search the bacterial genome to predict which proteins use the Tat system, and in this study we have verified their results experimentally and found a significant number of signals that are recognised by this system. The next step is to attach these signals to medically important proteins so they can be secreted by the bacteria using the Tat system."

The foundation work for this project was started as part of the Biotechnology and Biological Sciences Research Council' s (BBSRC) Exploiting Genomics Initiative; more recently Prof Palmer's team has joined forces with the "Tat Machine Project", an EU-funded consortium of researchers from across Europe studying the Tat system.

In addition to using the Tat nanomachine to improve production of biopharmaceuticals, the consortium are studying the system in several different types of bacteria, including pathogenic species like E. coli O157 and Pseudomonas aeruginosa to explore Tat as a potential target for new antibiotics.

Source: Biotechnology and Biological Sciences Research Council

Explore further: Research reveals how our bodies keep unwelcome visitors out of cell nuclei

add to favorites email to friend print save as pdf

Related Stories

Video of virus-sized particle trying to enter cell

Feb 25, 2014

Tiny and swift, viruses are hard to capture on video. Now researchers at Princeton University have achieved an unprecedented look at a virus-like particle as it tries to break into and infect a cell. The technique they developed ...

The dual significance of bacterial protein secretion

Sep 26, 2012

Secretion of bacterial proteins is an essential biological process with biotechnological and biomedical impact on human health. European scientists studied a universal and widely conserved bacterial secretory ...

Quality-control mechanism found in bacteria

Aug 03, 2012

(Phys.org) -- Like quality-control managers in factories, bacteria possess built-in machinery that track the shape and quality of proteins trying to pass through their cytoplasmic membranes, Cornell biomolecular engineers ...

Recommended for you

A gut reaction

Nov 19, 2014

Queen's University biologist Virginia Walker and Queen's SARC Awarded Postdoctoral Fellow Pranab Das have shown nanosilver, which is often added to water purification units, can upset your gut. The discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.